Merrimack Pharmaceuticals
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-11.14-4.67-2.650.22-1.00-1.97-30.44-21.35-100.37-162.36-8.91-1.97
Price/Sales ratio
9.037.752.78N/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-9.08-3.76-1.601.100.682.425.753.698.0510.220.980.68
Price/Cash Flow ratio
-26.66-6.57-2.36-0.73-0.61-1.34-19.93-240.46-88.96-125.98-88.25-1.34
Price/Free Cash Flow ratio
-22.72-5.85-2.32-0.72-0.61-1.34-19.93-240.46-88.96-125.98-90.31-1.34
Price/Earnings Growth ratio
0.28-0.070.29-0.000.000.040.350.982.586.510.270.00
Dividend Yield
0.00%N/AN/A131.27%N/A63.47%N/AN/AN/AN/A199.40%63.47%
Profitability Indicator Ratios
Gross Profit Margin
100%99.94%95.20%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
-64.47%-145.16%-76.34%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
-81.31%-165.57%-106.40%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
-81.05%-165.76%-105.17%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
4.17%2.65%8.61%35.80%11.23%6.47%-0.46%-0.12%-0.19%-1.02%-1739.49%6.47%
Return on Assets
-52.49%-62.99%-186.22%402.32%-45.74%-105.90%-18.04%-16.64%-7.78%-6.15%-10.04%-45.74%
Return On Equity
81.54%80.44%60.42%490.24%-68.86%-122.84%-18.91%-17.30%-8.02%-6.29%-35.27%-68.86%
Return on Capital Employed
-139.44%-98.80%1634.38%-98.17%-88.91%-129.15%-17.94%-17.42%-8.98%-11.60%-1.01%-88.91%
Liquidity Ratios
Current Ratio
1.181.940.654.805.146.7421.48N/AN/AN/A10.775.14
Quick Ratio
1.181.900.484.805.146.7421.4826.1233.6643.5010.775.14
Cash ratio
0.321.780.244.721.355.9818.2325.2733.0013.5810.321.35
Days of Sales Outstanding
11.7626.5144.19N/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/A29.49K768.54N/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/A29.52K812.74N/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A40.06K178.69N/AN/A44.39N/AN/A154.20N/AN/A44.39
Cash Conversion Cycle
N/A-10.54K634.04N/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.751.092.66N/A0.16N/AN/AN/AN/AN/AN/AN/A
Debt Equity Ratio
-1.17-1.40-0.86N/A0.25N/AN/AN/AN/AN/AN/AN/A
Long-term Debt to Capitalization
22.893.49-6.33N/A0.20N/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
6.673.49-6.33N/A0.20N/AN/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
-3.63-6.73-2.38-2.76-68.59-17.84N/AN/AN/AN/A-12.83-68.59
Cash Flow to Debt Ratio
-0.28-0.40-0.78N/A-4.40N/AN/AN/AN/AN/AN/A-4.40
Company Equity Multiplier
-1.55-1.27-0.321.211.501.161.041.031.031.021.101.16
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.33-1.18-1.17N/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.171.121.011.001.001111111
Cash Flow Coverage Ratio
-0.28-0.40-0.78N/A-4.40N/AN/AN/AN/AN/AN/A-4.40
Short Term Coverage Ratio
-2.60N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
-0.00%N/AN/A29.65%N/A-125.54%N/AN/AN/AN/AN/A-125.54%